 Charles Schwab Investment Management Inc. lifted its position in Eidos Therapeutics Inc NASDAQ:EIDX by 7.3 in the fourth quarter, HoldingsChannel.com reports. The firm owned 46,479 shares of the companys stock after purchasing an additional 3,180 shares during the quarter. Charles Schwab Investment Management Inc.s holdings in Eidos Therapeutics were worth 2,668,000 at the end of ... 